Common Contracts
3 similar Credit Agreement contracts by Alion Science & Technology Corp, Alpharma Inc, King Pharmaceuticals Inc
CREDIT AGREEMENT Dated as of May 11, 2010, among KING PHARMACEUTICALS, INC., THE LENDERS NAMED HEREIN, CREDIT SUISSE AG, as Administrative Agent, as Collateral Agent and as Swingline Lender, CREDIT SUISSE SECURITIES (USA) LLC, BANK OF AMERICA, N.A.,...Credit Agreement • August 9th, 2010 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of May 11, 2010 (as further amended, supplemented or otherwise modified from time to time, this “Agreement”), among KING PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”); the Lenders (as defined in Article I); CREDIT SUISSE AG, a bank organized under the laws of Switzerland, acting through its Cayman Islands Branch, as administrative agent and collateral agent for the Lenders (in such capacities, respectively, the “Administrative Agent” and the “Collateral Agent”), and as swingline lender (in such capacity, the “Swingline Lender”), Credit Suisse Securities (USA) LLC, Bank of America, N.A., DnB NOR Bank ASA, SunTrust Bank and U.S. Bank National Association, as co-syndication agents (in such capacity, “Co-Syndication Agents”); and the Issuing Banks (as defined in Article I).
CREDIT AGREEMENT dated as of March 22, 2010, among ALION SCIENCE AND TECHNOLOGY CORPORATION, THE LENDERS PARTY HERETO and CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as Administrative Agent CREDIT SUISSE SECURITIES (USA) LLC, as Sole Bookrunner and Sole...Credit Agreement • March 25th, 2010 • Alion Science & Technology Corp • Services-engineering services • New York
CREDIT AGREEMENT dated as of March 22, 2010, among ALION SCIENCE AND TECHNOLOGY CORPORATION, a Delaware corporation (the “Borrower”), the LENDERS (as defined in Article I) and CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as administrative agent (in such capacity, including any successor thereto, the “Administrative Agent”) for the Lenders.
AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • December 15th, 2008 • Alpharma Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of April 19, 2007 as amended by Amendment No. 1 dated December 5, 2008 (as further amended, supplemented or otherwise modified from time to time, this “Agreement”), among KING PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”); the Lenders (as defined in Article I); CREDIT SUISSE, a bank organized under the laws of Switzerland, acting through its Cayman Islands Branch, as administrative agent and collateral agent for the Lenders (in such capacity, the “Administrative Agent” and the “Collateral Agent”), and as swingline lender (in such capacity, the “Swingline Lender”), Bank of America, N.A. and UBS Securities LLC, as co-syndication agents (in such capacity, “Co-Syndication Agents”); Citigroup Global Markets Inc., Wachovia Bank, National Association and The Royal Bank of Scotland plc, as co-documentation agents (in such capacity, the “Co-Documentation Agents”); U.S. Bank National Association, as managing agent (in such capacity, the “Managing Agent
